Hypertrophic cardiomyopathy (HCM) is one of the most common genetic cardiovascular diseases. The good news is HCM is highly treatable once it is recognized. The HCM: Accelerating Guideline-Driven Care online course provides educational resources to improve patient outcomes. Join our expert faculty, Matthew W. Martinez, MD, FACC, and Ahmad Masri, MD, FACC, for a new ACC CardiaCast. Listen as they discuss the newly approved cardiac myosin inhibitor, Mavacamten, for the treatment of hypertrophic cardiomyopathy and mechanisms of action. Accelerate your path to HCM diagnosis and treatment with practical, tangible solutions with this free online course.